Clinical trial
Effect of Growth Hormone in Children With Growth Hormone Deficiency
NCT00262249 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00262249 |
|---|---|
| Title | Effect of Growth Hormone in Children With Growth Hormone Deficiency |
| Official title | Effect of Growth Hormone in Children With Growth Hormone Deficiency and Idiopathic Short Stature |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Growth Hormone Disorder, Growth Hormone Deficiency in Children, Growth Disorder, Idiopathic Short Stature |
| Intervention type | Drug |
| Interventions | somatropin |
| Enrollment | 173 |
| Start date | Aug 1, 2000 |
| Primary completion | May 1, 2004 |
| Completion | May 1, 2004 |
| First posted | Dec 6, 2005 |
| Last update posted | Jan 18, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: